BIOINVENT INTERNATIONAL AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.3 SEK | 0.00% |
|
+10.74% | +22.36% |
Chart calendar BioInvent International AB
8ecbd73858a8.CzNQtR-UeJyuryv_nayvGpas2BhvOsapmvpHSW3eztE.e3km-zLyF9T41X2brYHpbKPjrCpaY6PwwKMwOV7vh5kyAzbMeK0n7dTeRA~eea52070ca9c4a9924894528eee43a8e
Upcoming events on BioInvent International AB
Past events on BioInvent International AB
| 2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
| 2024-04-09 | Investing in Oncology Forum |
| 2024-03-05 | Carnegie Healthcare Conference |
| 2024-02-25 | BIO CEO & Investor Conference |
| 2024-02-22 08:00 am | Q4 2023 Earnings Call |
| 2024-02-22 02:00 am | Q4 2023 Earnings Release |
| 2024-01-24 03:39 am | Redeye Theme: Fight Cancer |
| 2024-01-18 10:30 am | B. Riley Securities Oncology Conference - Track 2 |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-12-05 | San Antonio Breast Cancer Symposium |
| 2023-11-02 | Society for Immunotherapy of Cancer Meeting - Poster Number: 757 |
| 2023-11-02 | Society for Immunotherapy of Cancer Meeting - Poster Number: 1368 |
| 2023-10-26 08:00 am | Q3 2023 Earnings Call |
| 2023-10-26 02:00 am | Q3 2023 Earnings Release |
| 2023-10-24 | BioStock Life Science Fall Summit |
| 2023-09-23 | HBM Biopharma Summit |
| 2023-09-13 | Pareto Healthcare Seminar |
| 2023-08-30 02:00 am | Q2 2023 Earnings Release |
| 2023-06-12 | International Conference of Malignant Lymphoma - Publication Nr.: OT16 |
| 2023-06-08 01:00 pm | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 93,7 84,7 10.67% | 147 366 -59.74% | 19,4 67,3 -71.19% | 326 313 4.32% | 71,5 52,7 35.7% | 63,6 |
|
EBITDA Million SEK | Released Forecast Spread | -126 -123 -2.61% | -63,5 150 -142.38% | -264 -298 11.5% | -36,2 -52,0 30.39% | -354 -339 -4.32% | -535 |
|
EBIT Million SEK | Released Forecast Spread | -138 -135 -2.45% | -75,5 138 -154.6% | -278 -298 6.54% | -50,9 -52,2 2.38% | -370 -339 -9.29% | -535 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -139 -135 -2.71% | -76,3 138 -155.39% | -278 -298 6.61% | -42,5 -57,9 26.58% | -330 -319 -3.35% | -535 |
|
Net income Million SEK | Released Forecast Spread | -139 -135 -2.69% | -76,3 138 -155.39% | -278 -298 6.61% | -42,5 -44,4 4.37% | -330 -319 -3.42% | -964 |
|
EPS SEK | Released Forecast Spread | -7,75 -6,73 -15.09% | -2,66 6,88 -138.69% | -5,14 -6,05 15.1% | -0,69 -0,96 28.37% | -5,02 -4,95 -1.51% | -3,93 |
| Announcement Date | 27/02/20 | 23/02/21 | 23/02/22 | 22/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 4,90 54,1 -90.93% | 16,7 33,0 -49.52% | 271 33,0 720.93% | 17,9 8,19 118.94% | 20,6 7,46 176.65% | 16,3 8,00 103.13% | 13,1 9,00 45.5% | 26,8 8,00 234.96% | 15,3 9,00 70.21% |
|
EBITDA Million SEK | Released Forecast Spread | -75,2 -79,0 4.86% | -64,8 -98,0 33.86% | 169 -98,0 272.82% | -65,5 -77,0 14.93% | -75,2 -82,0 8.24% | -77,1 -83,0 7.13% | -92,7 -83,0 -11.63% | -77,1 -81,0 4.84% | -106 -82,0 -29.69% |
|
EBIT Million SEK | Released Forecast Spread | -78,8 -79,5 0.81% | -68,3 -97,0 29.6% | 166 -96,0 272.69% | -69,2 -76,6 9.75% | -79,3 -82,2 3.57% | -80,9 -83,0 2.48% | -96,8 -83,0 -16.57% | -81,3 -81,0 -0.39% | -111 -82,0 -35.25% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -78,8 -79,8 1.3% | -67,7 -97,0 30.16% | 167 -96,4 273.75% | -63,9 -76,1 16.07% | -78,3 -81,5 3.87% | -73,7 -82,2 10.34% | -88,3 -82,5 -7.12% | -71,1 -80,6 11.78% | -96,8 -81,2 -19.2% |
|
Net income Million SEK | Released Forecast Spread | -78,8 -79,8 1.3% | -67,7 -97,0 30.16% | 167 -96,4 273.75% | -63,9 -76,1 16.07% | -78,3 -81,5 3.87% | -73,7 -82,2 10.34% | -88,3 -82,5 -7.12% | -71,1 -80,6 11.78% | -97,0 -81,2 -19.45% |
|
EPS SEK | Released Forecast Spread | -1,35 -1,36 1.07% | -1,16 -1,67 30.54% | 2,86 -1,16 346.06% | -1,00 -1,17 14.62% | -1,21 -1,25 3.53% | -1,12 -1,27 11.52% | -1,34 -1,27 -5.55% | -1,08 -1,24 12.9% | -1,48 -1,11 -33.63% |
| Announcement Date | 23/02/22 | 27/04/22 | 25/08/22 | 27/10/22 | 22/02/23 | 26/04/23 | 30/08/23 | 26/10/23 | 22/02/24 |
More events
Past sector events for BioInvent International AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BINV Stock
- Calendar BioInvent International AB
